Literature DB >> 22017436

OX40 and CD30 signals in CD4(+) T-cell effector and memory function: a distinct role for lymphoid tissue inducer cells in maintaining CD4(+) T-cell memory but not effector function.

David R Withers1, Fabrina M Gaspal, Vasileios Bekiaris, Fiona M McConnell, MiYeon Kim, Graham Anderson, Peter J L Lane.   

Abstract

CD4(+) effector and memory T cells play a pivotal role in the development of both normal and pathogenic immune responses. This review focuses on the molecular and cellular mechanisms that regulate their development, with particular focus on the tumor necrosis factor superfamily members OX40 (TNFRSF4) and CD30 (TNFRSF8). We discuss the evidence that in mice, these molecular signaling pathways act synergistically to regulate the development of both effector and memory CD4(+) T cells but that the cells that regulate memory versus effector function are distinct, effectively allowing the independent regulation of the memory and effector CD4(+) T-cell pools.
© 2011 John Wiley & Sons A/S.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22017436     DOI: 10.1111/j.1600-065X.2011.01057.x

Source DB:  PubMed          Journal:  Immunol Rev        ISSN: 0105-2896            Impact factor:   12.988


  22 in total

Review 1.  Brentuximab vedotin.

Authors:  Niels W C J van de Donk; Eugen Dhimolea
Journal:  MAbs       Date:  2012-07-01       Impact factor: 5.857

2.  Immunology: An innate regulatory cell.

Authors:  Marco Colonna
Journal:  Nature       Date:  2013-06-06       Impact factor: 49.962

Review 3.  The TNF family in T cell differentiation and function--unanswered questions and future directions.

Authors:  Michael Croft
Journal:  Semin Immunol       Date:  2014-03-06       Impact factor: 11.130

Review 4.  Trial Watch: Immunomodulatory monoclonal antibodies for oncological indications.

Authors:  Aitziber Buqué; Norma Bloy; Fernando Aranda; Francesca Castoldi; Alexander Eggermont; Isabelle Cremer; Wolf Hervé Fridman; Jitka Fucikova; Jérôme Galon; Aurélien Marabelle; Radek Spisek; Eric Tartour; Laurence Zitvogel; Guido Kroemer; Lorenzo Galluzzi
Journal:  Oncoimmunology       Date:  2015-03-02       Impact factor: 8.110

Review 5.  The TNF Receptor Superfamily in Co-stimulating and Co-inhibitory Responses.

Authors:  Lindsay K Ward-Kavanagh; Wai Wai Lin; John R Šedý; Carl F Ware
Journal:  Immunity       Date:  2016-05-17       Impact factor: 31.745

Review 6.  Clinical targeting of the TNF and TNFR superfamilies.

Authors:  Michael Croft; Chris A Benedict; Carl F Ware
Journal:  Nat Rev Drug Discov       Date:  2013-01-21       Impact factor: 84.694

Review 7.  The meninges: new therapeutic targets for multiple sclerosis.

Authors:  Abigail E Russi; Melissa A Brown
Journal:  Transl Res       Date:  2014-09-01       Impact factor: 7.012

8.  Inhibition of LTi cell development by CD25 blockade is associated with decreased intrathecal inflammation in multiple sclerosis.

Authors:  Justin S A Perry; Sungpil Han; Quangang Xu; Matthew L Herman; Lucy B Kennedy; Gyorgy Csako; Bibiana Bielekova
Journal:  Sci Transl Med       Date:  2012-08-01       Impact factor: 17.956

Review 9.  Functional interactions between innate lymphoid cells and adaptive immunity.

Authors:  Gregory F Sonnenberg; Matthew R Hepworth
Journal:  Nat Rev Immunol       Date:  2019-07-26       Impact factor: 53.106

10.  Cutting edge: lymphoid tissue inducer cells maintain memory CD4 T cells within secondary lymphoid tissue.

Authors:  David R Withers; Fabrina M Gaspal; Emma C Mackley; Clare L Marriott; Ewan A Ross; Guillaume E Desanti; Natalie A Roberts; Andrea J White; Adriana Flores-Langarica; Fiona M McConnell; Graham Anderson; Peter J L Lane
Journal:  J Immunol       Date:  2012-08-01       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.